Patient-reported outcomes with selpercatinib treatment in patients with RET-driven cancers in the phase I/II LIBRETTO-001 trial
-
Published:2024-05
Issue:5
Volume:9
Page:103444
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Raez L.E.,
Kang H.ORCID,
Ohe Y.ORCID,
Khanal M.,
Han Y.,
Szymczak S.ORCID,
Barker S.S.ORCID,
Gilligan A.M.
Funder
Eli Lilly and Company